What has FDA cited under 21 CFR 211.68?

1 DSRV article cite 21 CFR 211.68. Enforcement cases behind them: Anthropic Managed Agents (July 2026 public beta) read against Purolea Cosmetics Lab FDA Warning Letter (April 2026). Inspection exposure across them: 1 high.

What does DSRV recommend for 21 CFR 211.68?

From the newest article (Your Next 483 Observation Is Running on a Timer): Defining the QU boundary, validation basis, and change-control wrapper around autonomous agent actions is the firm's job, not the vendor's — settle it before a scheduled agent fires. DSRV is decision support, not legal advice; verify against the official source each article names.

Browse by regulation1 article · 1 high

21 CFR 211.68

Every DSRV article whose Regulatory Snapshot cites 21 CFR 211.68: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set

What has FDA cited under 21 CFR 211.68?: 1 DSRV article cite 21 CFR 211.68. Enforcement cases behind them: Anthropic Managed Agents (July 2026 public beta) read against Purolea Cosmetics Lab FDA Warning Letter (April 2026). Inspection exposure across them: 1 high.
What does DSRV recommend for 21 CFR 211.68?: From the newest article (Your Next 483 Observation Is Running on a Timer): Defining the QU boundary, validation basis, and change-control wrapper around autonomous agent actions is the firm's job, not the vendor's — settle it before a scheduled agent fires. DSRV is decision support, not legal advice; verify against the official source each article names.

July 20266 min readHigh exposurecited as a tag
Your Next 483 Observation Is Running on a Timer
Anthropic's July 2026 Managed Agents release ships scheduled autonomous runs and authenticated enterprise access. Pharma quality teams that have approved these capabilities without a QU review checkpoint built into the workflow architecture are building toward a Purolea-pattern inspection finding.
Case
Anthropic Managed Agents (July 2026 public beta) read against Purolea Cosmetics Lab FDA Warning Letter (April 2026)
DSRV take
Defining the QU boundary, validation basis, and change-control wrapper around autonomous agent actions is the firm's job, not the vendor's — settle it before a scheduled agent fires.

Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under 21 CFR 211.68. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about 21 CFR 211.68

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.